Heart Disease News and Research

Latest Heart Disease News and Research

Transformative potential of AI to enhance coronary heart disease detection

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary heart disease (CHD), the most common cause of mortality globally, poses a formidable challenge to modern healthcare systems.

2 Apr 2025

Weekend exercise can offer the same health benefits as daily workouts

Being physically active for one to two days a week, often called a "weekend warrior," may provide comparable health and life-prolonging benefits as smaller doses of daily physical activity if the physical effort is moderate to vigorous and totals 150 minutes a week in line with recommended guidelines for weekly physical activity, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

2 Apr 2025

How much will that surgery cost? 🤷 Hospital prices remain largely unhelpful.

It's a holy grail of health care: forcing the industry to reveal prices negotiated between health plans and hospitals — information that had long been treated as a trade secret.

2 Apr 2025

Rural communities face higher rates of heart disease and risk factors

A research team funded by the National Institutes of Health (NIH) uncovered higher rates of heart disease and worse heart health affecting adults living in rural communities compared to urban areas and the factors that likely drive these differences.

1 Apr 2025

Virtual diabetes self-management interventions improve blood sugar levels

Relatively inexpensive and accessible self-management interventions to help people manage Type 2 diabetes have been found to significantly reduce the blood sugar marker used to diagnose and manage the disease.

1 Apr 2025

Survey shows increased awareness of alcohol’s cancer risks

Public awareness of the link between drinking alcohol and an elevated risk of cancer has grown since last fall, with more than half of Americans now saying that regularly consuming alcohol increases your chances of later developing cancer, according to a survey by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

1 Apr 2025

Only 13% of French adults have optimal heart health—here’s what’s driving the gap

Only 13% of French adults aged 18–69 have optimal cardiovascular health, according to a national study using the American Heart Association’s Life’s Essential 8 (LE8) score. The findings highlight missed prevention opportunities and suggest that modest lifestyle changes could prevent up to 81% of cardiovascular events.

1 Apr 2025

Compound heatwaves linked to increased cardiac deaths

Cardiac deaths increase significantly during compound heatwaves-heatwaves where temperatures are elevated both during the day and overnight-according to a new study in JACC, the flagship journal of the American College of Cardiology.

1 Apr 2025

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

A New York City-based physician scientist who explores ways to improve health by looking at the ways in which cells and molecules impact disease and an epidemiologist from Baltimore who has devoted her career to identifying ways to improve screening, diagnosis and patient care for people with diabetes are the most recent American Heart Association Merit Award recipients.

1 Apr 2025

The evolution of OCT for retinal imaging and disease intervention

Dr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the future of ophthalmic diagnostics.

From Avantier Inc. 1 Apr 2025

WINREVAIR™ (sotatercept-csrk) reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for pulmonary arterial hypertension (PAH) by 76% compared to placebo in the phase 3 ZENITH trial

Merck, known as MSD outside of the United States and Canada, today announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR™ (sotatercept-csrk) compared to placebo in adults with pulmonary arterial hypertension (PAH, Group 1 PH) WHO* functional class (FC) III or IV at high risk of mortality who were on maximum tolerated background PAH therapy. At a median follow-up of 10.6 months (range, 0.3-26.1), WINREVAIR reduced the relative risk of major morbidity and mortality events (the composite of all-cause death, lung transplantation and PAH worsening-related hospitalization of ≥24 hours) by 76% (HR=0.24 [95% CI, 0.13-0.43]; p<0.0001 [1-sided]) compared to placebo.

1 Apr 2025

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD).

1 Apr 2025

Study shows women can hear better than men

An international team of scientists has found that biological sex is the leading factor explaining differences in hearing sensitivity, with women having significantly more sensitive hearing than men.

From University of Bath 1 Apr 2025

Study finds clues to hypertension hidden in electronic health records

A new study from investigators at Mass General Brigham shows that clues about hypertension may be buried in electronic health records (EHR).

1 Apr 2025

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical research presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in JACC.

31 Mar 2025

Study helps characterize how sleep deficiency may relate to Alzheimer's pathogenesis

New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer's disease over time.

31 Mar 2025

What blueberries do and don’t do for your microbiome and heart

Regular blueberry consumption for 12 weeks enriched Coriobacteriales incertae sedis in the gut microbiota of older overweight adults. However, this microbial shift was not linked to significant improvements in cardiometabolic biomarkers.

31 Mar 2025

Defibrillators and CPR cut marathon cardiac deaths in half, study shows

Researchers found that while the rate of cardiac arrests during U.S. marathons and half-marathons remained stable from 2010 to 2023, the likelihood of death from these events dropped by nearly half—thanks to faster emergency response and widespread use of defibrillators.

31 Mar 2025

Five lifestyle changes by 50 can add a decade to your life, global study finds

Study estimates the global lifetime risk and benefits of modifying cardiovascular risk factors like hypertension, smoking, and obesity by age 50, showing significant improvements in both life expectancy and quality of life. It highlights the importance of early intervention and midlife changes in preventing cardiovascular disease and mortality.

31 Mar 2025

Swedish researchers identify genetic variants linked to atherosclerosis

Swedish researchers have identified genetic variants that increase the risk of atherosclerosis. The aim is for these new findings to enable earlier detection of atherosclerosis and improved treatment of cardiovascular diseases such as heart attack and stroke.

31 Mar 2025

Previous
1
...
5
6
7
8
9
10
11
...
2911
Next

Heart Disease News and Research

Latest Heart Disease News and Research

Transformative potential of AI to enhance coronary heart disease detection

Weekend exercise can offer the same health benefits as daily workouts

How much will that surgery cost? 🤷 Hospital prices remain largely unhelpful.

Rural communities face higher rates of heart disease and risk factors

Virtual diabetes self-management interventions improve blood sugar levels

Survey shows increased awareness of alcohol’s cancer risks

Only 13% of French adults have optimal heart health—here’s what’s driving the gap

Compound heatwaves linked to increased cardiac deaths

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

The evolution of OCT for retinal imaging and disease intervention

WINREVAIR™ (sotatercept-csrk) reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for pulmonary arterial hypertension (PAH) by 76% compared to placebo in the phase 3 ZENITH trial

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Study shows women can hear better than men

Study finds clues to hypertension hidden in electronic health records

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

Study helps characterize how sleep deficiency may relate to Alzheimer's pathogenesis

What blueberries do and don’t do for your microbiome and heart

Defibrillators and CPR cut marathon cardiac deaths in half, study shows

Five lifestyle changes by 50 can add a decade to your life, global study finds

Swedish researchers identify genetic variants linked to atherosclerosis

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Heart Disease News and Research

Latest Heart Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in